“Increasing disease awareness will improve millions of cardiovascular patients worldwide.”
Andrew Ortega-Verdaguer, CEO IntelVasc
IntelVasc CEO Andrew Ortega-Verdaguer recently joined Omar M. Khateeb on the State of MedTech podcast to discuss the new frontiers in remote monitoring and innovation in cardiovascular care. This conversation highlighted the urgent need for improved disease awareness and cutting-edge technology to enhance patient outcomes.
Cardiovascular diseases (CVDs) are the leading cause of death worldwide, yet many patients remain unaware of their risks and symptoms. Unlike conditions such as cancer—where early detection often drives immediate action—cardiovascular issues, like femoral artery occlusions, are frequently overlooked until they become life-threatening. Raising awareness and adopting innovative monitoring solutions are key to addressing this global health crisis.
At IntelVasc, we are pioneering advancements in remote monitoring to bridge this gap. During the podcast discussion, we emphasized how real-time biosensors and AI-driven analytics can revolutionize patient care. By integrating these technologies, we are enabling continuous tracking of key cardiovascular indicators, allowing physicians to detect risks earlier and provide personalized, proactive treatments. These revolutionary biosensors and remote monitoring solutions will create a closer connection between doctors and patients, enabling clinicians to offer truly personalized care from the comfort of your own home.
By developing these advanced monitoring solutions, IntelVasc is transforming the relationship between patients and healthcare providers. Our vision is to allow clinicians to closely monitor patient health in real-time, reducing emergency interventions and significantly improving long-term outcomes.
Learn More:
Discover how IntelVasc is driving innovation in cardiovascular care. Watch Andrew Ortega-Verdaguer’s insightful interview on the State of MedTech podcast to learn about our mission and strategies for creating a healthier future. Listen to the full podcast here.
For more updates on our efforts to revolutionize cardiovascular care, connect with us on LinkedIn.
The information published in this Blog article, or in IntelVasc Inc. website, is provided for information purposes only and does not and cannot be considered as a consultation, treatment, therapy, or medical or clinical prescription, nor is it a substitute for treatment, diagnosis, therapy, or supervision by a healthcare professional. The information published is neither intended to be used as a guide and should not serve nor be used as an exclusive orientation for the healthcare professionals to make decisions about the treatment and therapy of their patients, nor does it replace the healthcare professionals’ criteria. IntelVasc Inc. makes no warranties as to the accuracy, suitability, or completeness of the information provided, and shall not be held responsible for any decisions made based on the information provided on this Blog article, IntelVasc Inc. website or any other websites linked or referenced in IntelVasc Inc. website.